Breaking News

Frontage Holdings Completes IPO

Proceeds from the global offering will be used to further expand the company's product development services capacity and capabilities

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Frontage Holdings Corp., the parent company of Frontage Laboratories, Inc., a contract research organization, specializing in R&D product development services, with operations in both the U.S. and China, has initiated trading on the Main Board of The Stock Exchange of Hong Kong. Proceeds from the Global Offering, after fees and estimated expenses, are estimated to be HK$1,515.41 million.   Frontage plans to leverage the proceeds to further expand the company’s product development ser...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters